Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
Cell Reports. Medicine
|
May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
Andrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Cell Reports
|
April 23, 2024
Mapping of susceptibility loci for Ebola virus pathogenesis in mice
Alexandra Schäfer, Andrea Marzi, Wakako Furuyama, et al.
Biorxiv : the Preprint Server for Biology
|
January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions
Andrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential
David R Martinez, Fernando R Moreira, Mark R Zweigart, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals
Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Science Translational Medicine
|
November 2, 2021
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
David R Martinez, Alexandra Schäfer, Sophie Gobeil, et al.
Nature Medicine
|
July 12, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2022
A Multitrait Locus Regulates Sarbecovirus Pathogenesis
Alexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.
Science Translational Medicine
|
May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
David R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Nature
|
June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques
Jingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
Cell Reports. Medicine
|
May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
Andrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Cell Reports
|
April 23, 2024
Mapping of susceptibility loci for Ebola virus pathogenesis in mice
Alexandra Schäfer, Andrea Marzi, Wakako Furuyama, et al.
Biorxiv : the Preprint Server for Biology
|
January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions
Andrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential
David R Martinez, Fernando R Moreira, Mark R Zweigart, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals
Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Science Translational Medicine
|
November 2, 2021
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
David R Martinez, Alexandra Schäfer, Sophie Gobeil, et al.
Nature Medicine
|
July 12, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2022
A Multitrait Locus Regulates Sarbecovirus Pathogenesis
Alexandra Schäfer, Sarah R Leist, Lisa E Gralinski, et al.
Science Translational Medicine
|
May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
David R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Nature
|
June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques
Jingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Page
of 12